Lixte Biotechnology appointed John Travaglini to its board, effective July 1, 2026.
| IndividualJohn Travaglini | RoleDirector | Type of ChangeAppointed | Effective DateJuly 1, 2026 | ReasonNot disclosed | Replacement InfoNot disclosed | Background DetailsWill participate in standard non-employee director compensation and enter into standard indemnification agreement (per proxy/Exhibit 10.3) | Board/Committee Role ChangesCommittee assignments not yet determined |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.